Scintigraphic visualization of ocular melanoma with Tc-99m glutathione.
In a patient with ocular melanoma scintigraphy obtained with 99mTc-GSH clearly demonstrated the histologically proven ocular lesion both in planar and SPECT images. 99mTc-sestamibi study obtained in the same patient three days later was negative. 99mTc-GSH is a potential alternative to the currently used radiopharmaceuticals for imaging both cutaneous and ocular melanomas and their metastases.
Tutuş
A
A
Department of Nuclear Medicine, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Erkiliç
K
K
Ercan
M T
MT
Kontaş
O
O
Aydin
M
M
Doğan
H
H
D005134:Eye Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D005978:Glutathione / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008545:Melanoma / Q000000981:diagnostic imaging* / Q000473:pathology; D008875:Middle Aged; D013667:Technetium; D017256:Technetium Tc 99m Sestamibi; D015899:Tomography, Emission-Computed, Single-Photon; D014057:Tomography, X-Ray Computed
C090285:technetium Tc 99m glutathione; D013667:Technetium; D017256:Technetium Tc 99m Sestamibi; D005978:Glutathione